← Latest Filings
L

Lynx1 Capital Management LP

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
25
$48.1M total
Open-market sells
0
$0 total
Tracking since
Nov 2024
Open-market buy — $295K
Korro Bio, Inc. · Oct 26, 2026
Open-market buy — $30K
Korro Bio, Inc. · Oct 23, 2026
Open-market trades from the last two years.
8,963,500 Common stock, $0.0001 par value per share in CGEM
Held indirectly (See footnote) · as of 2025-10-28
8,797,833 Common Stock in CGEM
Held indirectly (See footnote) · as of 2025-10-17
Korro Bio, Inc.
CIK 0001703647
TScan Therapeutics, Inc.
CIK 0001783328